Table 3.
COVID-19 (N = 49) | Control (N = 50) | |
---|---|---|
Total vaccination (N) | 23 (47%) | 36 (72%) |
BioNTech | 15 (65%) | 20 (55%) |
Johnson & Johnson | 5 (22%) | 9 (25%) |
Moderna | 3 (13%) | 7 (20%) |
COVID-19 (N = 49) | Control (N = 50) | |
---|---|---|
Total vaccination (N) | 23 (47%) | 36 (72%) |
BioNTech | 15 (65%) | 20 (55%) |
Johnson & Johnson | 5 (22%) | 9 (25%) |
Moderna | 3 (13%) | 7 (20%) |